Close X
Attorney Spotlight

Why did new member Mike Kuffner decide to pursue a legal career? Find out more>

Search

Close X

Experience

Search our Experience

Experience Spotlight

On December 1, 2016, Parker Hannifin Corporation and CLARCOR Inc. announced that the companies have entered into a definitive agreement under which Parker will acquire CLARCOR for approximately $4.3 billion in cash, including the assumption of net debt. The transaction has been unanimously approved by the board of directors of each company. Upon closing of the transaction, expected to be completed by or during the first quarter of Parker’s fiscal year 2018, CLARCOR will be combined with Parker’s Filtration Group to form a leading and diverse global filtration business. Bass, Berry & Sims has served CLARCOR as primary corporate and securities counsel for 10 years and served as lead counsel on this transaction. Read more here.

CLARCOR
Close X

Thought Leadership

Enter your search terms in the relevant box(es) below to search for specific Thought Leadership.
To see a recent listing of Thought Leadership, click the blue Search button below.

Thought Leadership Spotlight

www.BassBerryHRLawTalk.com image

A resource for employers featuring original and insightful commentary and review on important articles, cases and laws that affect the complicated and constantly changing labor industry or workplace.

Visit Now

Attorneys Dale Grimes and Lucas Smith Discuss the Federal Trade Commission's Continued Scrutiny of Healthcare Mergers for Inside Healthcare

Publications

September 17, 2012

Bass, Berry & Sims attorneys Dale Grimes and Lucas Smith discuss several examples of physician practice group mergers and acquisitions that have been the subject of enforcement actions by the Federal Trade Commission (FTC) and the state attorneys general. With the cases highlighted in their article, Dale and Lucas warn that antitrust enforcers continue to focus on the healthcare sector, especially provider-side combinations. No matter how small the merger, the FTC and state AGs are committed to taking action against anti-competitive mergers. As shown by the cases they cite, antitrust review frequently occurs after the merger or acquisition has closed leading to some novel remedies other than forced divestiture. The article, titled "FTC Continues to Scrutinize Healthcare Mergers," appears on Inside Healthcare.


Related Professionals

Related Services

Notice

Visiting, or interacting with, this website does not constitute an attorney-client relationship. Although we are always interested in hearing from visitors to our website, we cannot accept representation on a new matter from either existing clients or new clients until we know that we do not have a conflict of interest that would prevent us from doing so. Therefore, please do not send us any information about any new matter that may involve a potential legal representation until we have confirmed that a conflict of interest does not exist and we have expressly agreed in writing to the representation. Until there is such an agreement, we will not be deemed to have given you any advice, any information you send may not be deemed privileged and confidential, and we may be able to represent adverse parties.